CLASS III Drug recall · Reported 6 Jul 2016 · FDA Enforcement Report

Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg recalled

Lupin Pharmaceuticals is recalling Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, distributed nationwide in the US. The recall was initiated on 4 Apr 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: a) H303459, b) H303460, Exp 09/2016
NDC68180-518, 68180-519, 68180-520
UPC0368180519010, 0368180518013, 0368180520016
Quantity recalled59,520 Bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1052-2016
FDA event ID
73848
Recalling firm
Lupin Pharmaceuticals, Baltimore, MD
Manufacturer
Lupin Pharmaceuticals, Inc.
Classification
Class III
Status
Terminated
Recall initiated
4 Apr 2016
FDA classified
24 Jun 2016
Reported
6 Jul 2016
Type
Voluntary: Firm initiated
Customers notified by
E-Mail

Timeline

4 Apr 2016Recall initiated by company
24 Jun 2016Classified by FDA+81 days
6 Jul 2016Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Product as listed by the FDA

Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-count bottles and b) 5000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 India, a) NDC 68180-519-01, b) 68180-519-30

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Is Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg recalled?

Yes. Lupin Pharmaceuticals recalled Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg on 4 Apr 2016. The recall is Class III and its status is Terminated. Recall number D-1052-2016.

Why was it recalled?

CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Which lots are affected?

Lot #: a) H303459, b) H303460, Exp 09/2016

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Lupin Pharmaceuticals

All 123
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClobetasol Propionate Cream USP, 05% tube recalledClobetasol PropionateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIprednisoLONE Acetate Ophthalmic Suspension recalledPrednisolone AcetateLupin PharmaceuticalsSterilityNationwide
DrugCLASS IIGlucagon Emergency Kit for Low Blood Sugar, Glucagon recalledGlucagonLupin PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILiraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutideLupin PharmaceuticalsParticulate MatterNationwide
DrugCLASS IISertraline Hydrochloride Tablets USP, 100 mg recalledSertraline HydrochlorideLupin PharmaceuticalsPackaging DefectsNationwide

Other Lisinopril recalls

All 34